BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 371860)

  • 1. Changes in pituitary gonadotropins during the amenorrhoea-galactorrhoea syndrome due to sulpiride.
    Buvat J; Thomas K; Racadot A; Blacker C; Buvat-Herbaut M; Ferin F; Linquette M
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):499-504. PubMed ID: 371860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
    Onda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide.
    Aono T; Shioji T; Kinugasa T; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1978 Sep; 47(3):675-80. PubMed ID: 122411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin response to luteinizing hormone releasing hormone administration in secondary amenorrhea and galactorrhea syndromes.
    Wentz AC; Jones GS; Rocco L; Matthews RR
    Obstet Gynecol; 1975 Mar; 45(3):256-62. PubMed ID: 1089929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ Study of prolactin and blood gonadotropins in amenorrheas-galactorrhea. Dynamic exploation in 13 cases].
    Schaison G; Nathan C; L'Hermite M; Gilbert-Dreyfus
    Nouv Presse Med; 1975 Mar; 4(9):644-8. PubMed ID: 805417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amenorrhoea, galactorrhoea, and hyperprolactinaemia induced by methyldopa.
    Arze RS; Ramos JM; Rashid HU; Kerr DN
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):194. PubMed ID: 6789964
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.
    Tyson JE; Andreasson B; Huth J; Smith B; Zacur H
    Obstet Gynecol; 1975 Jul; 46(1):1-11. PubMed ID: 1153129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prolactin and gonadotrophin levels before and after luteinizing hormone-releasing hormone in the investigation of amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Br J Obstet Gynaecol; 1978 Dec; 85(12):945-56. PubMed ID: 367427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised serum prolactin levels in amenorrhoea.
    Seppălă M; Hibroven E; Ranta T; Virkkunen P; Leppăluoto J
    Br Med J; 1975 May; 2(5966):305-6. PubMed ID: 1093605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia.
    Simpson CW; Plunkett ER
    Fertil Steril; 1979 Nov; 32(5):510-7. PubMed ID: 115722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V; Kletzky O; March CM; Roy S; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.